Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2955)
All Articles published online
|
Apr 7, 2005 (publication date) through May 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tang TC, Poon RT, Lau CP, Xie D, Fan ST. Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma. World J Gastroenterol 2005; 11(13): 1896-1902 [PMID: 15800977 DOI: 10.3748/wjg.v11.i13.1896] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i13/1896.htm |
| Number | Citing Articles |
| 1 |
Yu Yang, Jiang Zhu, Hongfeng Gou, Dan Cao, Ming Jiang, Mei Hou. Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC). Medical Oncology 2011; 28(3): 796 doi: 10.1007/s12032-010-9519-y
|
| 2 |
Roberta WC Pang, Ronnie TP Poon. Clinical implications of angiogenesis in cancers. Vascular Health and Risk Management 2006; 2(2): 97 doi: 10.2147/vhrm.2006.2.2.97
|
| 3 |
Safiye Aktaş, Aydanur Kargı, Nur Olgun, Gulden Diniz, Ayşe Erbay, Canan Vergin. Prognostic significance of cyclooxygenase-2 expression in pediatric Hodgkin and non-Hodgkin lymphomas with or without Epstein–Barr virus latent infection. Comparative Clinical Pathology 2008; 17(2): 125 doi: 10.1007/s00580-007-0710-2
|
| 4 |
Qing Chen, Wenjia Lou, Junjie Shen, Leina Ma, Zhi Yang, Li Liu, Jingjing Luo, Cheng Qian. Potent Antitumor Activity in Experimental Hepatocellular Carcinoma by Adenovirus-Mediated Coexpression of TRAIL and shRNA against COX-2
. Clinical Cancer Research 2010; 16(14): 3696 doi: 10.1158/1078-0432.CCR-09-3097
|
| 5 |
Michael A. Kern, Anke M. Haugg, Eva Eiteneuer, Elisabeth Konze, Uta Drebber, Hans P. Dienes, Kai Breuhahn, Peter Schirmacher, Hans U. Kasper. Ex vivo analysis of antineoplastic agents in precision‐cut tissue slices of human origin: effects of cyclooxygenase‐2 inhibition in hepatocellular carcinoma. Liver International 2006; 26(5): 604 doi: 10.1111/j.1478-3231.2006.01268.x
|
| 6 |
Qing-Tao Zhao, Shu-Qiang Yue, Zhong Cui, Qi Wang, Xin Cui, Hui-Hong Zhai, Li-Hui Zhang, Ke-Feng Dou. Potential involvement of the cyclooxygenase-2 pathway in hepatocellular carcinoma-associated angiogenesis. Life Sciences 2007; 80(5): 484 doi: 10.1016/j.lfs.2006.09.038
|
| 7 |
SHAN-YU CHENG, HAI ZHANG, MIN ZHANG, SHU-KAI XIA, XIAO-MING BAI, LI ZHANG, JUAN MA, RONG RONG, YI-PIN WANG, MING-ZHAN DU, JIE WANG, MENG CHEN, FENG SHI, QIN-YI YANG, JING LENG. Prostaglandin E2 receptor EP2 mediates Snail expression in hepatocellular carcinoma cells. Oncology Reports 2014; 31(5): 2099 doi: 10.3892/or.2014.3074
|
| 8 |
Ponnuraj Nagendraprabhu, Ganapasam Sudhandiran. Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. Investigational New Drugs 2011; 29(2): 207 doi: 10.1007/s10637-009-9342-5
|
| 9 |
Rkia El-Kharrag, Amr Amin, Soleiman Hisaindee, Yaser Greish, Sherif M. Karam. Development of a therapeutic model of precancerous liver using crocin-coated magnetite nanoparticles. International Journal of Oncology 2017; 50(1): 212 doi: 10.3892/ijo.2016.3769
|
| 10 |
Chen Guangli, Liu Yingpeng, Wang Jianting, Luo Linghui, Chen Pei, Ding Juan, Gong Shusheng. Expression of vascular endothelial growth factor and cyclooxygenase-2 in laryngeal squamous cell carcinoma and its significance. Journal of Huazhong University of Science and Technology [Medical Sciences] 2006; 26(1): 105 doi: 10.1007/BF02828052
|
| 11 |
Mohamed S. Othman , Amal H. Al-Bagawi, Sofian T. Obeidat, Mohamed A. Fareid, Ola A. Habotta, Ahmed E. Abdel Moneim. Antitumor Activity of Zinc Nanoparticles Synthesized with Berberine on Human Epithelial
Colorectal Adenocarcinoma (Caco-2) Cells through Acting on Cox-2/NF-kB
and p53 Pathways. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(10): 2002 doi: 10.2174/1871520621666211004115839
|
| 12 |
Muriel Mathonnet, Bernard Descottes, Denis Valleix, François Labrousse, Yves Denizot. VEGF in hepatocellular carcinoma and surrounding cirrhotic liver tissues. World Journal of Gastroenterology 2006; 12(5): 830-831 doi: 10.3748/wjg.v12.i5.830
|
| 13 |
Hitoshi Nagatsuka, Chong Huat Siar, Hidetsugu Tsujigiwa, Yoshio Naomoto, Phuu Pwint Han, Mehmet Gunduz, Toshio Sugahara, Akira Sasaki, Motowo Nakajima. Heparanase and cyclooxygenase-2 gene and protein expressions during progression of oral epithelial dysplasia to carcinoma. Annals of Diagnostic Pathology 2012; 16(5): 354 doi: 10.1016/j.anndiagpath.2012.02.004
|
| 14 |
Tomas Koltai, Larry Fliegel. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. Journal of Evidence-Based Integrative Medicine 2022; 27: 2515690X2110688 doi: 10.1177/2515690X211068826
|
| 15 |
Jin-Ching Lee, Wei-Chun Chen, Shou-Fang Wu, Chin-kai Tseng, Ching-Yi Chiou, Fang-Rong Chang, Shih-hsien Hsu, Yang-Chang Wu. Anti-hepatitis C virus activity of Acacia confusa extract via suppressing cyclooxygenase-2. Antiviral Research 2011; 89(1): 35 doi: 10.1016/j.antiviral.2010.11.003
|
| 16 |
Sweeta R. Choudhari, Muhammad A. Khan, Genesis Harris, Donald Picker, Gary S. Jacob, Timothy Block, Kunwar Shailubhai. Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod. Molecular Cancer Therapeutics 2007; 6(1): 112 doi: 10.1158/1535-7163.MCT-06-0561
|
| 17 |
V. Sivaramakrishnan, S. Niranjali Devaraj. Morin regulates the expression of NF-κB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chemico-Biological Interactions 2009; 180(3): 353 doi: 10.1016/j.cbi.2009.02.004
|
| 18 |
Piera Federico, Emilio Francesco Giunta, Andrea Tufo, Francesco Tovoli, Angelica Petrillo, Bruno Daniele. Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact. Cancers 2022; 14(24): 6245 doi: 10.3390/cancers14246245
|
| 19 |
Tong Wu. Cyclooxygenase-2 in hepatocellular carcinoma. Cancer Treatment Reviews 2006; 32(1): 28 doi: 10.1016/j.ctrv.2005.10.004
|
| 20 |
Roberta Pang, Ronnie T.P. Poon. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Letters 2006; 242(2): 151 doi: 10.1016/j.canlet.2006.01.008
|
| 21 |
Ying Lu, Ling-Ling Liu, Shou-Sheng Liu, Zhi-Gang Fang, Yong Zou, Xu-Bin Deng, Zi-Jie Long, Quentin Liu, Dong-Jun Lin. Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cells. Journal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-1012-8
|
| 22 |
Patricia M. Santos, Ashley V. Menk, Jian Shi, Allan Tsung, Greg M. Delgoffe, Lisa H. Butterfield. Tumor-Derived α-Fetoprotein Suppresses Fatty Acid Metabolism and Oxidative Phosphorylation in Dendritic Cells. Cancer Immunology Research 2019; 7(6): 1001 doi: 10.1158/2326-6066.CIR-18-0513
|
| 23 |
B F Fernandes, J-C Marshall, S Di Cesare, P Logan, S Maloney, M N Burnier. Amfenac increases the radiosensitivity of uveal melanoma cell lines. Eye 2008; 22(5): 701 doi: 10.1038/sj.eye.6703042
|
| 24 |
Maria Luisa Balmer, Jean-François Dufour. Hepatocellular Carcinoma:. 2011; : 21 doi: 10.1007/978-1-60327-522-4_2
|
| 25 |
Alexander Ivanov, Birke Bartosch, Olga Smirnova, Maria Isaguliants, Sergey Kochetkov. HCV and Oxidative Stress in the Liver. Viruses 2013; 5(2): 439 doi: 10.3390/v5020439
|
| 26 |
James E. Talmadge, Moses Donkor, Eric Scholar. Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer and Metastasis Reviews 2007; 26(3-4): 373 doi: 10.1007/s10555-007-9072-0
|
| 27 |
Akemi Iwamoto, Masahide Ikeguchi, Sachico Matsumoto, Youji Hukumoto, Masashi Inoue, Tomohiro Ozaki, Masayuki Ataka, Takashi Tanida, Kanenori Endo, Kuniyuki Katano, Yasuaki Hirooka. Tumor Cyclooxygenase-2 Gene Suppresses Local Immune Responses in Patients with Hepatocellular Carcinoma. Tumori Journal 2006; 92(2): 130 doi: 10.1177/030089160609200208
|
| 28 |
Tenzin Choedon, Ganeshan Mathan, Soneera Arya, Vijay L Kumar, Vijay Kumar. Anticancer and cytotoxic properties of the latex of Calotropis procera in a transgenic mouse model of hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(16): 2517-2522 doi: 10.3748/wjg.v12.i16.2517
|
| 29 |
Soon Ha Kwon, Soung Won Jeong, Jae Young Jang, Ji Eun Lee, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, So-Young Jin. Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma. Clinical and Molecular Hepatology 2012; 18(3): 287 doi: 10.3350/cmh.2012.18.3.287
|
| 30 |
Firouzeh Korangy, Bastian Höchst, Michael P Manns, Tim F Greten. Immunotherapy of hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2010; 4(3): 345 doi: 10.1586/egh.10.18
|
| 31 |
Nam Oak Lee, Joong-Won Park, Jung Ahn Lee, Ju Hyun Shim, Sun-Young Kong, Kyung Tae Kim, Yeon-Su Lee. Dual action of a selective cyclooxygenase-2 inhibitor on vascular endothelial growth factor expression in human hepatocellular carcinoma cells: novel involvement of discoidin domain receptor 2. Journal of Cancer Research and Clinical Oncology 2012; 138(1): 73 doi: 10.1007/s00432-011-1075-0
|
| 32 |
Chenze Zhang, Wenqiang Yan, Bi Li, Bing Xu, Yan Gong, Fuhao Chu, Yuzhong Zhang, Qiuli Yao, Penglong Wang, Haimin Lei. A New Ligustrazine Derivative-Selective Cytotoxicity by Suppression of NF-κB/p65 and COX-2 Expression on Human Hepatoma Cells. Part 3. International Journal of Molecular Sciences 2015; 16(7): 16401 doi: 10.3390/ijms160716401
|
| 33 |
Ulrike Puhlmann, Dirk Schäfer, Christina Ziemann. Update on COX-2 inhibitor patents with a focus on optimised formulation and therapeutic scope of drug combinations making use of COX-2 inhibitors. Expert Opinion on Therapeutic Patents 2006; 16(4): 403 doi: 10.1517/13543776.16.4.403
|
| 34 |
Nektaria Makrilia, Theodora Lappa, Vassilia Xyla, Ilias Nikolaidis, Kostas Syrigos. The role of angiogenesis in solid tumours: An overview. European Journal of Internal Medicine 2009; 20(7): 663 doi: 10.1016/j.ejim.2009.07.009
|
| 35 |
M. Schuchmann. Disease Progression and Disease Prevention in Hepatology and Gastroenterology. Falk Symposium 2006; 150: 247 doi: 10.1007/1-4020-5224-3_24
|
| 36 |
Ingun Heiene Tveteraas, Kristin Meisdalen Müller, Monica Aasrum, John Ødegård, Olav Dajani, Tormod Guren, Dagny Sandnes, Thoralf Christoffersen. Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells. Journal of Experimental & Clinical Cancer Research 2012; 31(1) doi: 10.1186/1756-9966-31-72
|
| 37 |
Hai-Yan Wang, Hai-Zhong Yu, Sheng-Mou Huang, Yu-Lan Zheng. p53, Bcl-2 and cox-2 are involved in berberine hydrochloride-induced apoptosis of HeLa229 cells. Molecular Medicine Reports 2016; 14(4): 3855 doi: 10.3892/mmr.2016.5696
|
| 38 |
Ana Campillo, Estela Solanas, Maria J. Morandeira, Tomas Castiella, Sara Lorente, Francisco Agustín Garcia-Gil, Elena Piazuelo, Alba de Martino, Maria T. Serrano. Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation. European Journal of Gastroenterology & Hepatology 2014; 26(8): 871 doi: 10.1097/MEG.0000000000000131
|
| 39 |
Jin Lee, Kye-Taek Lim. Inhibitory effect of phytoglycoprotein (24 kDa) on hepatocarcinogenesis in N-nitrosodiethylamine-treated ICR mice. Journal of Pharmacy and Pharmacology 2011; 63(6): 840 doi: 10.1111/j.2042-7158.2011.01277.x
|
| 40 |
Gopalakrishnan Ramakrishnan, Carmen Martha Elinos-Báez, Sundaram Jagan, Titto Alby Augustine, Sattu Kamaraj, Pandi Anandakumar, Thiruvengadam Devaki. Silymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinoma. Molecular and Cellular Biochemistry 2008; 313(1-2): 53 doi: 10.1007/s11010-008-9741-5
|
| 41 |
Fang Zheng, Yi-Ji Liao, Mu-Yan Cai, Tian-Hao Liu, Shu-Peng Chen, Pei-Hong Wu, Long Wu, Xiu-Wu Bian, Xin-Yuan Guan, Yi-Xin Zeng, Yun-Fei Yuan, Hsiang-Fu Kung, Dan Xie, Peter McKinnon. Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets. PLOS Genetics 2015; 11(2): e1004873 doi: 10.1371/journal.pgen.1004873
|
| 42 |
Ganji Purnachandra Nagaraju, Bassel F. El‐Rayes. Cyclooxygenase‐2 in gastrointestinal malignancies. Cancer 2019; 125(8): 1221 doi: 10.1002/cncr.32010
|
| 43 |
Roberta W. C. Pang, Jae Won Joh, Philip J. Johnson, Morito Monden, Timothy M. Pawlik, Ronnie T. P. Poon. Biology of Hepatocellular Carcinoma. Annals of Surgical Oncology 2008; 15(4): 962 doi: 10.1245/s10434-007-9730-z
|
| 44 |
H Chen, W Cai, E S H Chu, J Tang, C-C Wong, S H Wong, W Sun, Q Liang, J Fang, Z Sun, J Yu. Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice. Oncogene 2017; 36(31): 4415 doi: 10.1038/onc.2017.73
|
| 45 |
T. Chi-Man Tang, R. Tung-Ping Poon, S.-T. Fan. The significance of cyclooxygenase-2 expression in human hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2005; 59: S311 doi: 10.1016/S0753-3322(05)80053-8
|
| 46 |
Jaya Gandhi, Lohit Khera, Nivedita Gaur, Catherine Paul, Rajeev Kaul. Role of Modulator of Inflammation Cyclooxygenase-2 in Gammaherpesvirus Mediated Tumorigenesis. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.00538
|
| 47 |
Katarzyna Owczarek, Urszula Lewandowska. The Impact of Dietary Polyphenols on COX-2 Expression in Colorectal Cancer. Nutrition and Cancer 2017; 69(8): 1105 doi: 10.1080/01635581.2017.1367940
|
| 48 |
Shah Jahan, Saba Khaliq, Bushra Ijaz, Waqar Ahmad, Sajida Hassan. Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-155
|
| 49 |
Sattu Kamaraj, Pandi Anandakumar, Sundaram Jagan, Gopalakrishnan Ramakrishnan, Thiruvengadam Devaki. Modulatory effect of hesperidin on benzo(a)pyrene induced experimental lung carcinogenesis with reference to COX-2, MMP-2 and MMP-9. European Journal of Pharmacology 2010; 649(1-3): 320 doi: 10.1016/j.ejphar.2010.09.017
|
| 50 |
Francesco Semeraro, Andrea Russo, Elena Gambicorti, Sarah Duse, Francesco Morescalchi, Sara Vezzoli, Ciro Costagliola. Efficacy and vitreous levels of topical NSAIDs. Expert Opinion on Drug Delivery 2015; 12(11): 1767 doi: 10.1517/17425247.2015.1068756
|
| 51 |
Moustafa A. Sakr, Mahmood A. Al-Azzawi, Anis Anis, Amal A. Abd El-Aziz, Mohamed E. Ebeid, Mahmoud A. Shokeer, Aysam fayed. The correlation between P53 and COX-2 expression and the pathological alteration in hepatocellular carcinoma. Egyptian Journal of Medical Human Genetics 2022; 23(1) doi: 10.1186/s43042-022-00230-y
|
| 52 |
Muriel Mathonnet, Bernard Descottes, Denis Valleix, François Labrousse, Véronique Truffinet, Yves Denizot. Quantitative analysis using ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal cancer, liver metastasis of colorectal cancer and hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(23): 3782-3783 doi: 10.3748/wjg.v12.i23.3782
|
| 53 |
Carey L. McInnis, Elizabeth A. Giuliano, Philip J. Johnson, James R. Turk. Immunohistochemical evaluation of cyclooxygenase expression in corneal squamous cell carcinoma in horses. American Journal of Veterinary Research 2007; 68(2): 165 doi: 10.2460/ajvr.68.2.165
|
| 54 |
WonHyung Choi, JongPhil Chu. The characteristics of the expression of heat shock proteins and cox-2 in the liver of hamsters infected with Clonorchis sinensis, and the change of endocrine hormones and cytokines. Folia Parasitologica 2012; 59(4): 255 doi: 10.14411/fp.2012.036
|
| 55 |
Zhen Fan Yang, Ronnie T.P. Poon. Vascular Changes in Hepatocellular Carcinoma. The Anatomical Record 2008; 291(6): 721 doi: 10.1002/ar.20668
|
| 56 |
Shah Jahan, Usman A Ashfaq, Muhammad Qasim, Saba Khaliq, Muhammad Javed Saleem, Nadeem Afzal. Hepatitis C virus to hepatocellular carcinoma. Infectious Agents and Cancer 2012; 7(1) doi: 10.1186/1750-9378-7-2
|
| 57 |
U. N. Tumanova, A. I. Shchegolev. Angiogenesis in hepatocellular carcinoma. Biology Bulletin Reviews 2015; 5(6): 568 doi: 10.1134/S2079086415060080
|
| 58 |
Giovanni Barsotti, Lorenzo Ressel, Riccardo Finotello, Veronica Marchetti, Francesca Millanta. Primary Corneal Squamous Cell Carcinoma in a Dog: Clinical and Histopathological Evaluation. Case Reports in Veterinary Medicine 2012; 2012: 1 doi: 10.1155/2012/596593
|
| 59 |
Bharat B Aggarwal, Prashasnika Gehlot. Inflammation and cancer: how friendly is the relationship for cancer patients?. Current Opinion in Pharmacology 2009; 9(4): 351 doi: 10.1016/j.coph.2009.06.020
|
| 60 |
María de Luján Alvarez, Florencia Lorenzetti. Role of eicosanoids in liver repair, regeneration and cancer. Biochemical Pharmacology 2021; 192: 114732 doi: 10.1016/j.bcp.2021.114732
|
| 61 |
Yong-Jiang Xu, Zhaojun Zheng, Chen Cao, Jinwei Li, Yuanfa Liu. Bioanalytical insights into the association between eicosanoids and pathogenesis of hepatocellular carcinoma. Cancer and Metastasis Reviews 2018; 37(2-3): 269 doi: 10.1007/s10555-018-9747-8
|
| 62 |
Chun-Chieh Yeh, Jaw-Town Lin, Long-Bin Jeng, Hsiu J. Ho, Horng-Ren Yang, Ming-Shiang Wu, Ken N. Kuo, Chun-Ying Wu. Nonsteroidal Anti-inflammatory Drugs Are Associated With Reduced Risk of Early Hepatocellular Carcinoma Recurrence After Curative Liver Resection. Annals of Surgery 2015; 261(3): 521 doi: 10.1097/SLA.0000000000000746
|
| 63 |
Teruhime Otoguro, Tomohisa Tanaka, Hirotake Kasai, Atsuya Yamashita, Kohji Moriishi. Inhibitory effect of presenilin inhibitor LY411575 on maturation of hepatitis C virus core protein, production of the viral particle and expression of host proteins involved in pathogenicity. Microbiology and Immunology 2016; 60(11): 740 doi: 10.1111/1348-0421.12448
|